Thursday, 8 August 2019
12pm to 2pm (12pm-Lunch, 1pm–Talk)
Farrer Park Medical Centre, 1 Farrer Park Station Road, Connexion #16-06, TK Low Academic Specialist Centre, Singapore 217562
Adhering to the surgical concept of precise liver resection, the Shanghai Renji Hospital performs complex operations of the liver, bile duct and gallbladder, and carry out various types of anatomical segment resection of liver tumor, hilar cholangiocarcinomaļ¼various angioplasty approaches, special segment resection combined with vascular reconstruction, and autologous liver transplantation.
The hospital also provides a full range of minimally-invasive (laparoscopic or robotic) procedures for selected patients and living donors requiring liver surgeries by highly experienced surgeons. About 30-40 % of liver tumor resections are performed using minimally invasive approaches. Laparoscopic resections based on liver segment, as well as living donor procurement are performed conventionally. Other systems include the Da Vinci Surgical Robot system, which offers high-resolution 3D view, and movements that simulate a human wrist to complete complex tumor resection and various anastomoses precisely.
The CME Lunch Talk will feature discussions on the minimally invasive procedures available, where patients can benefit from smaller incisions, faster recovery and a shorter hospital stay.
*This session is open to doctors and healthcare professionals only.
Lunch and complimentary parking will be provided. CME points will be awarded. Thank you.
Call us to register or email us at [email protected].
Vice President
Shanghai Renji Hospital
For the past 14 years, Prof. Xia Qiang has been responsible for the liver transplantation and liver surgery department at Renji Hospital. The unit has performed more than 4,400 cases of liver transplantation (LT), including over 1,700 pediatric LT. Specific interests within liver transplantation surgery include living donor, split liver and dual graft LT. More than 220 papers have been published. The research interests include ischemia/reperfusion injury, primary liver cancer and post-LT immune tolerance.
At present Prof. Xia serves as a Committee Member of International Liver Transplantation Society (ILTS), Committee Member of International Liver Transplantation Society Pediatric Branch, Executive Member of International Living Donor Liver Transplantation (ILDLT), Director of the professional committee of pediatric transplantation in Chinese Medical Association for organ transplantation, Elected-director of Shanghai Organ Transplantation Committee and members of editorial board for Journal of Chinese Transplantation and the Chinese Digestive Surgery.
Director
Liver Surgery Department International Service, Shanghai Renji Hospital
Prof. Xue Feng is an expert reviewer of National Natural Science Foundation of China (NSFC), Ministry of Education of China, Shanghai Science and Technology Commission and Shanghai Food and Drug Administration. She also takes some society responsibilities, such as deputy secretary of Chinese liver society DILI group, Vice-Chair of Children’s Genetically & Metabolic Liver Disease, and the Council Member of Shanghai Transplant Pathology Society.
Prof Xue’s clinical specialties are the diagnosis and treatment of end-stage liver disease, liver transplant-related medical complications, and management of pediatric liver transplantation. Her research interests mainly focus on clinical and basic research in immune monitoring and tolerance after liver transplantation. Her clinical routine includes preoperative evaluation, management of post-operative infection and rejection, ischemic and preserved liver injury, prevention and treatment of hepatitis B recurrence and fibrosis post-LT, targeted treatment of HCC, individualization of immunosuppressant post-LT and so on.
Prof Xue had studied in Japan, followed Professor Shiro Takahara, the ex-chairman of Japanese Organ Transplantation Society, and got her Ph.D degree in Japan in 2004. She has published more than fifty papers and participated in editorial work of undergraduate textbooks. She was awarded HANS POPPER PRIZE by Insertional Liver Society in 2000, and had participated in Chinese Pediatric Living donor Liver Transplantation Program, which won the first prize of Shanghai Medical Science and Technology Award (sixth completion), the first prize of Chinese Medical Science and Technology Award (fifth completion), and the first prize of Science and Technology Progress of Ministry of Education (fifth completion) in 2014, 2015 respectively.
